Describe the therapeutic benefits and potential adverse effects associated with HMG-CoA reductase inhibitors
Pleiotropic effects: NO synthesis, LDL lower, Inflammatory down; Adverse: myopathy; decrease Coenzyme Q10 -> impair energy in muscles = myalgia
Adalimumab - Drug Class, MOA, Indication, Side effect
Anti-TNF IgG1 Antibody; binds TNF-α + blocks interaction w/ surface TNF receptors; for UC/CD diseases; side effect-serious infection
Explain the rationale for utilizing sofosbuvir-velpatasvir in previously untreated hepatitis C
Velpatasvir: NS5A inhibitor; Sofosbuvir: NS5B polymerase inhibitor; both work by weakening the activity of proteins needed by hepatitis C
Elaborate the role of statin in the regulation of intracellular cholesterol synthesis
Statins inhibit HMG-CoA reductase->reduce cellular cholesterol synthesis->Lower intracellular cholesterol->over-expression of the LDL receptors=lower plasma LDL
Describe life-threatening complications from cirrhosis including hepatic encephalopathy (HE), spontaneous bacterial peritonitis (SBP), and esophageal varices (EV)
HE: toxin build up in blood->brain damage; SBP: infection of ascitic fluid in peritoneum; EV: blood flow to liver blocked->enlarged esophageal veins
Describe specific dietary modifications and medicinal foods (soy, green tea, flax, olive oil) for dyslipidemia.
soy-reduces HMG-CoA reductase; Green Tea Extract and Green Tea-reduces FA gene expression, inhibits HMG-CoA reductase; flax-reduce LDL
Mesalamine (5-aminosalicylic acid (5-ASA): drug class, MOA, indication, side effect
Sulfasalazine; inhibit production of inflammatory mediators from both cyclooxygenase & lipoxygenase pathways; induce/remission UC+CD; sulfonamide toxicity
Compare and contrast the histological findings of Ulcerative Colitis (UC) and Chron Disease (CD)
UC: loss of hostra, pseudopolyp, ulcers, crypt distortion; CD: transmural inflammation,ulcerations,fissures; cobblestoning, thickened wall
Describe the pathophysiology, risk factors, and clinical features of celiac disease
genetic(HLA DQ 2,8)+exposure to prolamins->TTG alter + gliadin w/ zonulin -> IgA against TTG + tight junctions open = inflammation GI ->malabsorption-diarrhea
Explain the pathogenesis of hepatitis B virus
transmitted by blood/sexual contact/transplacentally->hepatocytes->dsDNA->mRNA viral proteins->dsDNA packaged->viral antigens attached by CTL-> acute hepatitis
Explain how insulin resistance can lead to the development of hepatic steatosis
skeletal resistance -> glucose to liver; adipose resistance -> lipolysis = glycerol + Fatty acids -> fats deposited in liver
Describe the role of gliadin, zonulin, and tight junctions in maintenance of the intestinal barrier
In celiac disease, explain how malabsorption can result in osmotic diarrhea
damaged villi + mucosa --> Osmotic diarrhea=osmotically active, poorly absorbed solutes in the bowel lumen->inhibit normal water + electrolyte absorption
Explain the use of osmotic laxatives (lactulose) to manage hepatic encephalopathy.
colonic acidifier that works by decreasing the amount of ammonia in the blood (decrease intestinal production/absorption of ammonia) -> less toxin to brain
Explain how hepatocellular oxidative injury can result in hepatic inflammation and necrosis
Reactive oxygen species produced in mitochondria + ER of hepatocytes via cytochrome P450-> imbalance oxidants/antioxidants=structural & functional abnormality
shifting dullness: ascites sign, Percuss across abdomen-transition tympany to dull; palmar erythema: red palms from oestradiol; asterixis: negative myoclonus
Discuss the Batts-Ludwig grading and staging criteria
Grade-amount of necroinflammatory activity; Stage-amount of fibrosis
Explain the pathogenesis of hepatitis C virus
human reservoir→transmission by blood, semen, in utero→infects hepatocytes→immune response by CTLs kills infected hepatocytes=acute hepatitis
Identify common comorbidities of NAFLD
hepatic manifestation of metabolic syndrome linked with insulin resistance; obesity, dyslipidemia, diabetes
Describe the immunologic mechanisms resulting in hepatic injury from hepatitis
immune system–mediated cytotoxicity: (HLA) class I–restricted CD8 CTL's recognize hepatitis B core antigen + e antigen on infected hepatocytes->inflammation
Your experience on this site will be improved by allowing cookies.